The call for stricter warning labels are a result of the increased risk of serious fungal infections associated with the drugs. Specifically, the FDA reported 240 cases of histoplasmosis in patients taking the drugs. Histoplasmosis is a respiratory disease with flu like symptoms. If untreated the disease is deadly.
For the full story, read the Wall Street Journal's article here.
Published On: September 04, 2008